A small number of cancers (basal cell carcinoma, breast cancer, malignant melanoma, lipoma, squamous cell carcinoma) were reported during the 12-week oral METAOD005 trial
Injectable GHK-Cus primary side effect involves injection site reactions
Medical billers and coders often find it hard to append the correct J-Code in the claim form
High blood potassium levels and symptoms related to polycythemia vera, a blood disorder, can occur
Practical combination approaches include topical serums containing both peptides, alternating injection sites (GHK-Cu subcutaneous, AHK-Cu scalp mesotherapy), or using GHK-Cu via microneedling with AHK-Cu in a topical serum applied after
FIP is an inflammatory disease that impairs several functions of the body including the GI (gastrointestinal) tract